Pliant Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
PLRX
CUSIP
729139105
Type
Equity
Class
COM
Num filings
149
Total reported value, excl. options
$1.16 B
Manager Report Date Value ($000) Shares Option Type